Synapse - Starting at the front line in metastatic pancreatic cancers: As new options emerge, how do you select and sequence?

Starting at the front line in metastatic pancreatic cancers: As new options emerge, how do you select and sequence? Miscellaneous

Authors:	Wainberg, Z. A.; Bekaii-Saab, T.; O'Reilly, E.; Pant, S.
Title:	Starting at the front line in metastatic pancreatic cancers: As new options emerge, how do you select and sequence?
Keywords:	mutation; drug efficacy; drug resistance, neoplasm; clinical trials; progression-free survival; education, continuing (credit); chemotherapy, cancer; pancreatic neoplasms -- therapy; medical practice, evidence-based; neoplasm metastasis -- therapy
Journal Title:	Oncology (Norwalk)
Volume:	38
Issue:	9
ISSN:	0890-9091
Publisher:	C M P Medica LLC * The Oncology Group
Date Published:	2024-09-01
Start Page:	352
End Page:	354
Language:	English
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=rzh&AN=179918449&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	CME activity -- Accession Number: 179918449 -- Entry Date: 20240930 -- Revision Date: 20240930 -- Publication Type: Journal Article; CEU; pictorial -- Note: For CE see https://gotoper.com/mxf24pancreatic -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- Special Interest: Oncologic Care -- NLM UID: 8712059. -- Source: CINAHL Plus with Full Text

MSK Authors